Exemestane Prescribing at WIGHT PRIMARY PARTNERSHIPS LTD
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
98
Total Quantity
3,596
NHS Cost
£651
vs National Avg
+201.6%
WIGHT PRIMARY PARTNERSHIPS LTD prescribed 98 items of Exemestane over the last 12 months at a cost of £651 to the NHS. This is 201.6% above the national average prescribing rate. Exemestane is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
7
Jun 2026
10
Jun 2026
7
Jun 2026
9
Jun 2026
10
Jun 2026
10
Jun 2026
8
Jun 2026
10
Jun 2026
9
Jun 2026
6
Jun 2026
6
Jun 2026
6
Prescribing Details
| Total Items | 98 |
|---|---|
| Total Quantity | 3,596 |
| Total NHS Cost | £651 |
| Presentations | 1 different forms |
| vs National Average | +201.6% |
Exemestane Prescribing Comparison
| This practice | 98 items |
|---|---|
| National average per practice | 33 items |
| Difference | +201.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.